Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Miriam Redrado"'
Autor:
Francisco Exposito, Miriam Redrado, Diego Serrano, Silvia Calabuig-Fariñas, Aida Bao-Caamano, Sandra Gallach, Eloisa Jantus-Lewintre, Angel Diaz-Lagares, Aitor Rodriguez-Casanova, Juan Sandoval, Edurne San Jose-Eneriz, Javier Garcia, Esther Redin, Yaiza Senent, Sergio Leon, Ruben Pio, Rafael Lopez, Julen Oyarzabal, Antonio Pineda-Lucena, Xabier Agirre, Luis M. Montuenga, Felipe Prosper, Alfonso Calvo
Publikováno v:
Cell Death and Disease, Vol 15, Iss 11, Pp 1-16 (2024)
Abstract The treatment of non-small cell lung cancer (NSCLC) patients has significantly improved with recent therapeutic strategies; however, many patients still do not benefit from them. As a result, new treatment approaches are urgently needed. In
Externí odkaz:
https://doaj.org/article/6e85bcef9c6c4041a19b62d5fdc24ce3
Autor:
Karmele Valencia, Cristina Sainz, Cristina Bértolo, Gabriel de Biurrun, Jackeline Agorreta, Arantza Azpilikueta, Marta Larrayoz, Graziella Bosco, Carolina Zandueta, Miriam Redrado, Esther Redín, Francisco Exposito, Diego Serrano, Mirari Echepare, Daniel Ajona, Ignacio Melero, Ruben Pio, Roman Thomas, Alfonso Calvo, Luis M. Montuenga
Publikováno v:
Disease Models & Mechanisms, Vol 15, Iss 1 (2022)
There is a paucity of adequate mouse models and cell lines available to study lung squamous cell carcinoma (LUSC). We have generated and characterized two models of phenotypically different transplantable LUSC cell lines, i.e. UN-SCC679 and UN-SCC680
Externí odkaz:
https://doaj.org/article/c6029081bc0342b6bd4394720dcdfdaf
Autor:
Alberto Mantovani, Marco Erreni, Paola Allavena, Diego Serrano, Miriam Redrado, Francisco Exposito, Alfonso Calvo, Clément Anfray, Francesco Mainini, Elisabeth Digifico, Akihiro Maeda, Marina Sironi, Achille Anselmo, Aldo Ummarino, Sara Gandoy, Marvin Martens, Susana Bravo, Fernando Torres Andón
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Externí odkaz:
https://doaj.org/article/3f2b3bd851e44e92a41caf3c42431605
Autor:
Jackeline Agorreta, Ana Remirez, Ruben Pio, Luis M Montuenga, Teresa Lozano, Esther Redin, Irati Garmendia, Diego Serrano, Yaiza Senent, Miriam Redrado, Maria Villalba, Francisco Exposito, Daniel Ajona, Sergio Ortiz-Espinosa, Cristina Bertolo, Cristina Sainz, Juana Garcia-Pedrero, Juan Lasarte, Alfonso Calvo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Introduction The use of immune-checkpoint inhibitors has drastically improved the management of patients with non-small cell lung cancer (NSCLC), but innate and acquired resistances are hurdles needed to be solved. Immunomodulatory drugs that can rei
Externí odkaz:
https://doaj.org/article/168f0e31c2614696a5307d18a104e8ba
Autor:
Leyre Larzabal, Nefertiti El-Nikhely, Miriam Redrado, Werner Seeger, Rajkumar Savai, Alfonso Calvo
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79798 (2013)
Cancer stem cells (CSCs) are thought to be responsible for tumor initiation and recurrence after chemotherapy. Targeting CSCs and non-CSCs with specific compounds may be an effective approach to reduce lung cancer growth and metastasis. The aim of th
Externí odkaz:
https://doaj.org/article/0a4e777d8d2d40b0a291d24333dea86a
Autor:
Ignacio Gil-Bazo, Alfonso Calvo, Luis M. Montuenga, Jesús García-Foncillas, Carlos E. García-Franco, Ignacio I. Wistuba, Carmen Behrens, Ruben Pio, Miriam Redrado, María D. Lozano, Jackeline Agorreta, María J. Pajares, Paul A. Nguewa, Mariano Ponz-Sarvisé
Supplementary Figure 2 from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56bce0ef69575df56fd3109e67d255b1
https://doi.org/10.1158/1078-0432.22441852.v1
https://doi.org/10.1158/1078-0432.22441852.v1
Autor:
Ignacio Gil-Bazo, Alfonso Calvo, Luis M. Montuenga, Jesús García-Foncillas, Carlos E. García-Franco, Ignacio I. Wistuba, Carmen Behrens, Ruben Pio, Miriam Redrado, María D. Lozano, Jackeline Agorreta, María J. Pajares, Paul A. Nguewa, Mariano Ponz-Sarvisé
Supplementary Figure 3 from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8e91f2ce4a47c8e9690d92e68d7b4a
https://doi.org/10.1158/1078-0432.22441849.v1
https://doi.org/10.1158/1078-0432.22441849.v1
Autor:
Ignacio Gil-Bazo, Alfonso Calvo, Luis M. Montuenga, Jesús García-Foncillas, Carlos E. García-Franco, Ignacio I. Wistuba, Carmen Behrens, Ruben Pio, Miriam Redrado, María D. Lozano, Jackeline Agorreta, María J. Pajares, Paul A. Nguewa, Mariano Ponz-Sarvisé
Purpose: High inhibitor of differentiation-1 (Id1) levels have been found in some tumor types. We aimed to study Id1 levels and their prognostic impact in a large series of stages I to IV non-small cell lung cancer (NSCLC) patients. Experiments in ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8929210f40bb201e088714c35c4912
https://doi.org/10.1158/1078-0432.c.6518746.v1
https://doi.org/10.1158/1078-0432.c.6518746.v1
Autor:
Ignacio Gil-Bazo, Alfonso Calvo, Luis M. Montuenga, Jesús García-Foncillas, Carlos E. García-Franco, Ignacio I. Wistuba, Carmen Behrens, Ruben Pio, Miriam Redrado, María D. Lozano, Jackeline Agorreta, María J. Pajares, Paul A. Nguewa, Mariano Ponz-Sarvisé
Supplementary Figure 4 from Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41928dbf309922964267f8078b44bfca
https://doi.org/10.1158/1078-0432.22441846
https://doi.org/10.1158/1078-0432.22441846
Autor:
Francesco Bertolini, Alfonso Calvo, Miriam Redrado, Celia Prior, Angelica Calleri, Giuliana Gregato, Paola Marighetti, Ines Martin-Padura, Alice Agliano
Purpose: Blastic natural killer (NK) cell lymphoma/blastic plasmacytoid dendritic cell neoplasm (BNKL) is a rare and aggressive neoplasia characterized by infiltration of blast CD4+/CD56+ cells in the skin, the bone marrow, and peripheral blood. Curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8cbbae34e00b20a9c939d6ede211f75
https://doi.org/10.1158/1078-0432.c.6520346.v1
https://doi.org/10.1158/1078-0432.c.6520346.v1